Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Percheron Therapeutics Ltd
ASX:PER

Watchlist Manager
Percheron Therapeutics Ltd Logo
Percheron Therapeutics Ltd
ASX:PER
Watchlist
Price: 0.008 AUD -11.11% Market Closed
Market Cap: AU$8.7m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
-45%
5Y
+132%
10Y
+62%
Liabilities
+
3Y
+88%
5Y
+196%
10Y
+305%
Equity
+
3Y
-53%
5Y
+121%
10Y
+41%

Balance Sheet Decomposition
Percheron Therapeutics Ltd

Balance Sheet
Percheron Therapeutics Ltd

Rotate your device to view
Balance Sheet
Currency: AUD
Jun-2002 Jun-2003 Jun-2004 Jun-2005 Jun-2006 Jun-2007 Jun-2008 Jun-2009 Jun-2010 Jun-2011 Jun-2012 Jun-2013 Jun-2014 Jun-2015 Jun-2016 Jun-2017 Jun-2018 Jun-2019 Jun-2020 Jun-2021 Jun-2022 Jun-2023 Jun-2024 Jun-2025
Assets
Cash & Cash Equivalents
9
7
14
9
8
8
6
3
2
2
5
4
1
7
5
2
2
3
4
6
1
0
0
1
Cash
0
0
0
0
0
0
1
1
1
1
0
1
0
0
0
0
0
0
0
0
1
0
0
1
Cash Equivalents
9
7
14
9
8
8
5
3
1
2
5
3
1
7
5
2
2
3
4
6
0
0
0
0
Short-Term Investments
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18
11
12
10
Total Receivables
0
0
0
0
0
0
3
2
0
0
1
1
1
1
0
0
0
1
1
1
2
2
3
2
Accounts Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
1
1
1
0
2
3
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
2
Other Current Assets
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
1
0
0
1
Total Current Assets
10
7
15
9
9
8
10
5
2
2
6
5
3
8
5
3
5
4
5
7
22
13
14
12
PP&E Net
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
PP&E Gross
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Intangible Assets
6
4
3
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
15
N/A
12
-22%
18
+52%
11
-38%
9
-19%
8
-12%
10
+23%
5
-49%
2
-64%
2
+34%
6
+133%
5
-9%
3
-49%
8
+189%
5
-31%
3
-52%
5
+89%
4
-23%
5
+45%
7
+31%
22
+220%
13
-43%
15
+13%
12
-14%
Liabilities
Accounts Payable
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
1
0
1
0
1
4
1
Accrued Liabilities
2
0
1
0
0
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
1
0
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
1
Total Current Liabilities
2
0
1
0
0
2
3
1
0
0
0
1
1
1
1
1
1
1
1
1
1
3
5
2
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Liabilities
2
N/A
0
-81%
1
+183%
0
-65%
0
-11%
2
+534%
4
+74%
1
-70%
0
-56%
0
-11%
0
N/A
1
+31%
1
+4%
1
+4%
1
+26%
1
-9%
1
-15%
1
+53%
1
-8%
1
+55%
1
+2%
3
+121%
5
+80%
2
-53%
Equity
Common Stock
19
24
34
34
37
39
41
41
42
45
50
52
52
57
57
58
62
64
69
77
98
98
109
112
Retained Earnings
6
12
17
23
28
33
35
38
41
43
44
47
50
50
52
56
58
61
65
71
77
88
100
102
Total Equity
13
N/A
12
-14%
17
+47%
11
-37%
9
-19%
6
-32%
6
+5%
4
-38%
1
-66%
2
+51%
5
+161%
5
-12%
2
-55%
7
+239%
5
-35%
2
-60%
4
+128%
3
-33%
5
+61%
6
+26%
21
+269%
10
-53%
9
-6%
10
+7%
Total Liabilities & Equity
15
N/A
12
-22%
18
+52%
11
-38%
9
-19%
8
-12%
10
+23%
5
-49%
2
-64%
2
+34%
6
+133%
5
-9%
3
-49%
8
+189%
5
-31%
3
-52%
5
+89%
4
-23%
5
+45%
7
+31%
22
+220%
13
-43%
15
+13%
12
-14%
Shares Outstanding
Common Shares Outstanding
36
46
59
59
77
89
95
95
98
106
141
160
160
196
179
180
372
420
489
574
669
669
902
1 087

See Also

Summary
PER intrinsic value, competitors valuation, and company profile.
DCF Valuation
PER stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PER stock valuation using valuation multiples.
Wall Street Estimates
PER price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PER stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 314,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.